Cormorant Asset Management LP 13D and 13G filings for Stoke Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2021-02-16 3:15 pm Sale | 2021-02-16 | 13G | Stoke Therapeutics, Inc. STOK | Cormorant Asset Management LP | 1,437,807 3.970% | -350,856 (-19.62%) | Filing |